|
Total rifampicin-associated reports
|
37,812
|
192
|
|
Drug reactions with eosinophilia and systemic symptoms (PT)
|
305 (0.8)
|
9 (5)
|
|
Events of hepatic disorders reported with terms of Immune system disorder (SOC)
|
n.d.*
|
n.d.*
|
|
Hepatitis (PT)
|
74 (0.2)
|
3 (2)
|
|
Jaundice (PT)
|
26 (0.1)
|
–
|
|
Acute hepatic failure (PT)
|
12 (< 0.1)
|
2 (1)
|
|
Hepatic function abnormal (PT)
|
25 (0.1)
|
–
|
|
Hepatic enzymes increase (incl. ALT, transaminases) (PT)
|
52 (0.1)
|
3 (2)
|
|
Other hepatic terms reported
|
Not done
|
4 (2)
|
|
Lower respiratory tract inflammatory and immunological conditions (HLGT)
|
35 (0.1)
|
2 (1)
|
|
Pneumonitis (PT)
|
9 (< 0.1)
|
–
|
|
Hemolytic anemia, hemolysis, autoimmune hemolytic anemia (PT)**
|
187 (0.5)
|
2 (1)
|
|
Tubulointerstitial nephritis, nephritis, allergic nephritis (PT)***
|
160 (0.4)
|
6 (3)
|
